Smart jab can shrink head and neck cancer tumours within six weeks, trial finds ⊖
Triple-action therapy drug amivantamab could be given as an injection to help treat recurrent or metastatic cancers
Doctors have hailed “incredibly encouraging” trial results that show a triple-action…